Community Research and Development Information Service - CORDIS


Over the last decade there has been a significant revival in the development of Boron Neutron Capture Therapy (BNCT) as a treatment modality for curing cancerous tumours, such as glioblastoma multiforme and (sub)cutaneous malignant melanoma. This paper provides an introduction to the principles of BNCT and indicates how present techniques have overcome the problems that gave rise to the negative results of the first clinical trials on BNCT in the United States in the 1950s and 1960s. In 1988, a European Concerted Action group on BNCT was formed, funded by the Medical and Health Research Programme of the CEC, with the aim of promoting BNCT in Europe. The group has two prime tasks: to initiate clinical trials of glioma at the earliest possible date at the High Flux Reactor in Petten, and to create suitable conditions for the treatment of other tumours at Petten and other European sites. The paper considers both tasks in detail.

Additional information

Authors: MOSS R L, JRC Petten (NL)
Bibliographic Reference: Paper presented: VI National Meeting of the Spanish Association of Radiotherapy and Oncology, Palma de Mallorca (ES), Dec. 11-14, 1991
Availability: Available from (1) as Paper EN 36537 ORA
Record Number: 199210060 / Last updated on: 1994-12-02
Original language: en
Available languages: en